BRPI0810962A2 - Formulações de aminoácidos n-halogenados com compostos anti-inflamatórios - Google Patents
Formulações de aminoácidos n-halogenados com compostos anti-inflamatóriosInfo
- Publication number
- BRPI0810962A2 BRPI0810962A2 BRPI0810962-1A2A BRPI0810962A BRPI0810962A2 BR PI0810962 A2 BRPI0810962 A2 BR PI0810962A2 BR PI0810962 A BRPI0810962 A BR PI0810962A BR PI0810962 A2 BRPI0810962 A2 BR PI0810962A2
- Authority
- BR
- Brazil
- Prior art keywords
- halogened
- amino acid
- inflammatory compounds
- acid formulations
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91527707P | 2007-05-01 | 2007-05-01 | |
PCT/US2008/061956 WO2008137444A1 (en) | 2007-05-01 | 2008-04-30 | N-halogenated amino acid formulations with anti-inflammatory compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0810962A2 true BRPI0810962A2 (pt) | 2015-01-27 |
Family
ID=39495776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0810962-1A2A BRPI0810962A2 (pt) | 2007-05-01 | 2008-04-30 | Formulações de aminoácidos n-halogenados com compostos anti-inflamatórios |
Country Status (15)
Country | Link |
---|---|
US (2) | US20080275122A1 (pt) |
EP (1) | EP2139519A1 (pt) |
JP (1) | JP2010526085A (pt) |
KR (1) | KR20100017159A (pt) |
CN (1) | CN101687041A (pt) |
AR (1) | AR066372A1 (pt) |
AU (1) | AU2008247788A1 (pt) |
BR (1) | BRPI0810962A2 (pt) |
CA (1) | CA2684186A1 (pt) |
CL (1) | CL2008001282A1 (pt) |
MX (1) | MX2009011818A (pt) |
RU (1) | RU2009144286A (pt) |
TW (1) | TW200901957A (pt) |
UY (1) | UY31058A1 (pt) |
WO (1) | WO2008137444A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009126912A1 (en) * | 2008-04-10 | 2009-10-15 | Novabay Pharmaceuticals, Inc. | Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections |
WO2009127924A1 (en) * | 2008-04-15 | 2009-10-22 | Waldemar Gottardi | Compositions and devices for antisepsis and anticoagulation |
US9642780B2 (en) | 2011-06-15 | 2017-05-09 | Rls Global Ab | Detection and removal of carious dentin tissue |
SE536581C2 (sv) | 2012-07-24 | 2014-03-11 | Rls Global Ab | Ett kit för behandling av sår eller liknande och ett preparat och metoder därav |
US20140227201A1 (en) * | 2013-02-13 | 2014-08-14 | Novabay Pharmaceuticals, Inc. | Antimicrobial Gel Formulations |
KR102253324B1 (ko) * | 2019-11-27 | 2021-05-18 | 단디바이오사이언스 주식회사 | 호흡기 질환의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1325382C (en) * | 1988-01-27 | 1993-12-21 | Takahiro Ogawa | Locally administrable therapeutic composition for inflammatory disease |
US5421818A (en) * | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
US6156728A (en) * | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
AU2001261748A1 (en) * | 2000-05-19 | 2001-12-03 | Alcon Laboratories Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
JP4502641B2 (ja) * | 2002-01-24 | 2010-07-14 | ティルタン ファーマ リミテッド | 抗癌組み合わせおよびその使用方法 |
PL1656095T3 (pl) * | 2003-08-18 | 2014-04-30 | Novabay Pharmaceuticals Inc | N,n-dwuchlorowcowane kwasy aminowe i pochodne |
TWI386201B (zh) * | 2005-01-25 | 2013-02-21 | Novabay Pharmaceuticals Inc | N-鹵化胺基酸、n,n-二鹵化胺基酸與其衍生物;以及使用其之組合物與方法 |
UY31059A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado |
-
2008
- 2008-04-29 UY UY31058A patent/UY31058A1/es not_active Application Discontinuation
- 2008-04-30 EP EP08780580A patent/EP2139519A1/en not_active Withdrawn
- 2008-04-30 US US12/112,352 patent/US20080275122A1/en not_active Abandoned
- 2008-04-30 CA CA002684186A patent/CA2684186A1/en not_active Abandoned
- 2008-04-30 KR KR1020097024160A patent/KR20100017159A/ko not_active Application Discontinuation
- 2008-04-30 MX MX2009011818A patent/MX2009011818A/es unknown
- 2008-04-30 WO PCT/US2008/061956 patent/WO2008137444A1/en active Application Filing
- 2008-04-30 BR BRPI0810962-1A2A patent/BRPI0810962A2/pt not_active IP Right Cessation
- 2008-04-30 RU RU2009144286/15A patent/RU2009144286A/ru not_active Application Discontinuation
- 2008-04-30 JP JP2010506590A patent/JP2010526085A/ja not_active Withdrawn
- 2008-04-30 CN CN200880013887A patent/CN101687041A/zh active Pending
- 2008-04-30 TW TW097115859A patent/TW200901957A/zh unknown
- 2008-04-30 AR ARP080101843A patent/AR066372A1/es not_active Application Discontinuation
- 2008-04-30 AU AU2008247788A patent/AU2008247788A1/en not_active Abandoned
- 2008-05-02 CL CL2008001282A patent/CL2008001282A1/es unknown
-
2010
- 2010-04-26 US US12/767,420 patent/US20100210730A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101687041A (zh) | 2010-03-31 |
MX2009011818A (es) | 2009-11-13 |
WO2008137444A1 (en) | 2008-11-13 |
US20080275122A1 (en) | 2008-11-06 |
UY31058A1 (es) | 2008-10-31 |
EP2139519A1 (en) | 2010-01-06 |
JP2010526085A (ja) | 2010-07-29 |
AU2008247788A1 (en) | 2008-11-13 |
TW200901957A (en) | 2009-01-16 |
KR20100017159A (ko) | 2010-02-16 |
US20100210730A1 (en) | 2010-08-19 |
AR066372A1 (es) | 2009-08-12 |
CA2684186A1 (en) | 2008-11-13 |
RU2009144286A (ru) | 2011-06-10 |
CL2008001282A1 (es) | 2009-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
LTPA2018005I1 (lt) | Farmacinė kompozicija | |
NO20093032L (no) | Topiske formuleringer med økt biotilgjengelighet | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
BRPI0913379A2 (pt) | formulações farmacêuticas sólidas compreendendo bibw 2992 | |
BRPI0810928A2 (pt) | "composição farmacêutica" | |
BRPI0811110A2 (pt) | Formulação de nicotina oral tamponada com aminoácido | |
BRPI0913806A2 (pt) | "composição" | |
RU2493831C3 (ru) | Фармацевтические композиции | |
BRPI0913945A2 (pt) | agentes anti-inflamatórios | |
NO20090578A (no) | Farmasøytisk sammensetning inneholdende en tetrahydrofolsyre | |
DK1868586T3 (da) | Antiinflammatorisk formulering | |
BRPI0814188A2 (pt) | Formulações | |
BRPI0911743A2 (pt) | "peptídeo" | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
DK2234994T3 (da) | Fedtsyre-butylester-blandinger | |
ATE509925T1 (de) | Substituierte bicyclocarbonsäureamidverbindungen | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
BRPI0609066A2 (pt) | composição de ácido tereftálico | |
BRPI0815332A2 (pt) | Composto de ácido fenilacético | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
BRPI0820198A2 (pt) | composições farmacêuticas | |
BRPI0811864A2 (pt) | Derivados de ácido cistéico de peptídeos antivirais | |
DK2185151T3 (da) | Antiinflammatorisk sammensætning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |